Director/PDMR Shareholding

RNS Number : 3351I
GlaxoSmithKline PLC
01 July 2013
 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan notified the Company and the under-mentioned Connected Persons on 28 June 2013 of an increase in their notional interests in Ordinary Shares at a price of 1565.50 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $48.52 per ADS following the notional re-investment of the dividend paid to shareholders on 11 April 2013.

 

 

Director/PDMR

 

Connected Person

 

Ordinary Shares

 

ADSs

 

Dr M M Slaoui

 

Dr K Slaoui


 

28.847

 

Mr P C Thomson

 

Mrs K Thomson

 

27.347


 

The notional dividends accrued will be paid out in proportion to the percentage of the participant's Performance Share Plan holdings that vest following the end of the relevant three-year measurement period.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).

 

 

V A Whyte

Company Secretary

 

1 July 2013

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEFLFBXDFEBBX

Companies

GSK (GSK)
UK 100